United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2011_register
executive
2011-08-18
article
Branded Prescription Drug Fee
Proposed Rules
D09002ee1bdcf9e95
D09002ee1bdcf9f47
United States
Department of the Treasury
originator
org
United States Government Agency or Subagency
United States
Internal Revenue Service
originator
org
United States Government Agency or Subagency
In the Rules and Regulations section of this issue of the Federal Register, the IRS is issuing temporary regulations relating to the branded prescription drug fee imposed by the Affordable Care Act (ACA). The regulations affect persons engaged in the business of manufacturing or importing certain branded prescription drugs. The text of the temporary regulations also serves as the text of the proposed regulations.
76 FR 51310
https://www.govinfo.gov/app/details/FR-2011-08-18/2011-21012
2011-21012
fr18au11-14
RIN 1545-BJ39
4830-01-P
REG-112805-10
https://www.govinfo.gov/app/details/FR-2011-08-18/2011-21012
https://www.govinfo.gov/content/pkg/FR-2011-08-18/html/2011-21012.htm
https://www.govinfo.gov/content/pkg/FR-2011-08-18/pdf/2011-21012.pdf
Drugs
Reporting and Recordkeeping Requirements
2 p.
51310
51311
76 FR 51310
Code of Federal Regulations
Title 26 Part 51
26 CFR Part 51
Regulation Identification Number 1545-BJ39
RIN 1545-BJ39
Branded Prescription Drug Fee; Federal Register Vol. 76, Issue
PRORULE
2011-21012
DEPARTMENT OF THE TREASURY
Internal Revenue Service
2011-11-16
REG-112805-10
4830-01-P
2011-21012
Notice of proposed rulemaking by cross-reference to temporary regulations.
In the Rules and Regulations section of this issue of the Federal Register, the IRS is issuing temporary regulations relating to the branded prescription drug fee imposed by the Affordable Care Act (ACA). The regulations affect persons engaged in the business of manufacturing or importing certain branded prescription drugs. The text of the temporary regulations also serves as the text of the proposed regulations.
Written and electronic comments and requests for a public hearing must be received by November 16, 2011.
Concerning the proposed regulations, Celia Gabrysh at (202) 622-3130; concerning submissions of comments and requests for a hearing Richard.A.Hurst@irscounsel.treas.gov, (202) 622- 7180 (not toll free numbers).
Drugs
Reporting and Recordkeeping Requirements
Branded Prescription Drug Fee
,
Richard.A.Hurst@irscounsel.treas.gov
http://www.regulations.gov
Federal Register
Vol. 76, no. 160
Office of the Federal Register, National Archives and Records Administration
2011-08-18
continuing
daily
deposited
born digital
634 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2011-08-18
P0b002ee180dd4502
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr18au11
https://www.govinfo.gov/app/details/FR-2011-08-18
https://www.govinfo.gov/content/pkg/FR-2011-08-18/pdf/FR-2011-08-18.pdf
https://www.govinfo.gov/content/pkg/FR-2011-08-18/xml/FR-2011-08-18.xml
fdlp
51245
51868
DGPO
2011-08-18
2023-04-30
FR-2011-08-18
machine generated
eng
FR
FR-2011-08-18
76
160